Press Releases
Syner-G Biopharma Group Announces Neil Butera as New Chief Commercial Officer
Bringing Depth and Breadth of Biotech Experience to Oversee Continued Growth BOSTON (PRWEB) APRIL 06, 2023 - Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and...
Syner-G BioPharma Group Acquires RMC Pharmaceutical Solutions
Expands Expertise in Biologics and Builds Scale in CMC and Quality Consulting Boston, MA, January 19, 2023 - Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and...
Syner-G Biopharma Group Announces Karen Casey as Chief People Officer
Rapid Growth Drives the Need for an Investment in Talent January 10, 2023, Boston, MA — Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to the pharmaceutical and medical device...
Syner-G Biopharma Group Appoints Ron Kraus as CEO
RESEARCH TRIANGLE PARK, NC: 13 June 2022 Syner-G BioPharma Group (“Syner-G”), a leading provider of consulting services to pharmaceutical and biotechnology clients, today announced that Ron Kraus has joined the company as Chief Executive Officer (CEO). Mr. Kraus has...
IMPACT’S Making an IMPACT Initiative Celebrates the Second Half of 2021
RESEARCH TRIANGLE PARK, NC: 01 March 2022 – In the second half of 2021, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. We continued our charitable and community outreach...
Syner-G Acquires IMPACT, Expands Services for Biotech and Pharma Companies
Boston, MA (February 1, 2022) - Syner-G BioPharma Group (“Syner-G” or the “Company”), a leading provider of Chemistry, Manufacturing, and Controls ("CMC") technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology clients, today...
IMPACT Celebrates Award from 200th Client
Research Triangle Park, NC—November 15, 2021 – In a virtual gathering, Impact Pharmaceutical Services, Inc. (IMPACT) (now Syner-G BioPharma Group) team members opened boxes specially curated to evoke the trust and mutual respect that has grown out of our relationships...
Syner-G Pharma Consulting Announces New Brand and Website; Company To Be Known as Syner-G Biopharma Group
- New brand reflects the company’s evolution to support market dynamics - Company provides more than traditional consulting services - Solutions to Chemistry, Manufacturing, & Controls challenges remains paramount Southborough, MA, October 6, 2021 – Prabu Nambiar,...
IMPACT’S Making an IMPACT Initiative Celebrates the First Half of 2021
RESEARCH TRIANGLE PARK, NC: 30 August 2021 – In the first half of 2021, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. As we all continued to work from home, our virtual...
IMPACT’S Making an IMPACT Initiative Celebrates 2020
RESEARCH TRIANGLE PARK, NC: 10 February 2021 – In 2020, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. The past year provided us opportunities to connect with various...
Riverside Partners Completes Investment in Syner-G
Boston, October 29, 2020 – Riverside Partners, LLC, a Boston-based private equity firm, announced today the completion of an investment in Syner-G Pharma Consulting, LLC (“Syner-G” or the “Company”) in partnership with the Company’s founders. Syner-G provides the full...
IMPACT’S Making an IMPACT Initiative Celebrates the Second Half of 2019
RESEARCH TRIANGLE PARK, NC: 29 January 2019 – In the second half of 2019, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. Together, we held several donation drives for...
Headquarters
100 Pennsylvania Avenue, Suite 310
Framingham, MA 01701
Contact Us
508.460.9700
info@synergbiopharma.com